Term Name:	3',4'-difluoro-N-{4'-fluoro-6-[(3S)-pyrrolidin-3-yloxy][biphenyl]-3-yl}-6-[(3S)-pyrrolidin-3-yloxy][biphenyl]-3-carboxamide
Synonyms:	3',4'-difluoro-N-(4'-fluoro-6-{[(3S)-pyrrolidin-3-yl]oxy}[1,1'-biphenyl]-3-yl)-6-{[(3S)-pyrrolidin-3-yl]oxy}[1,1'-biphenyl]-3-carboxamide, 3',4'-difluoro-N-{4'-fluoro-6-[(3S)-pyrrolidin-3-yloxy][biphenyl]-3-yl}-6-[(3S)-pyrrolidin-3-yloxy][biphenyl]-3-carboxamide
Definition:	A secondary carboxamide resulting from the formal condensation of the carboxy group of 3',4'-difluoro-6-[(3S)-pyrrolidin-3-yloxy][biphenyl]-3-carboxylic acid with the primary amino group of 4'-fluoro-6-[(3S)-pyrrolidin-3-yloxy][biphenyl]-3-amine. It is an beta-catenin/BCL9 protein-protein interaction inhibitor.
Ontology:	ChEBI [CHEBI:147294] ( EBI )

Relationships

is a type of:	aromatic ether diether difluorobenzene monofluorobenzenes pyrrolidines secondary carboxamide
has_role:	antineoplastic agent Wnt signalling inhibitor
inverse is_conjugate_acid_of:	3',4'-difluoro-N-{4'-fluoro-6-[(3S)-pyrrolidin-3-yloxy][biphenyl]-3-yl}-6-[(3S)-pyrrolidin-3-yloxy][biphenyl]-3-carboxamide(2+)
is_conjugate_base_of:	3',4'-difluoro-N-{4'-fluoro-6-[(3S)-pyrrolidin-3-yloxy][biphenyl]-3-yl}-6-[(3S)-pyrrolidin-3-yloxy][biphenyl]-3-carboxamide(2+)